CHICAGO: Advancements in drug discovery for neurodegenerative diseases could be boosted by greater cooperation between pharma companies and small research programs, says GlobalData.
Kyle S Nicholson, GlobalData’s analyst covering neurology, claims evolving ideas are constantly needed in the field that covers Parkinson’s and Alzheimer’s disease…